These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Venous thromboembolism in non-critically ill patients with COVID-19 infection. Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275 [TBL] [Abstract][Full Text] [Related]
13. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Miesbach W; Makris M Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459 [TBL] [Abstract][Full Text] [Related]
14. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? Thachil J; Srivastava A Semin Thromb Hemost; 2020 Oct; 46(7):777-780. PubMed ID: 32396963 [No Abstract] [Full Text] [Related]
15. PARP-inhibitors in a non-oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open. Capoluongo E Biomed Pharmacother; 2020 Oct; 130():110536. PubMed ID: 32688139 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926 [No Abstract] [Full Text] [Related]
17. Venous thromboembolism and COVID-19. Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397 [No Abstract] [Full Text] [Related]
18. Long lasting hypercoagulability after subclinical COVID-19. Ferroli P; Villa C; Ciuffi A; Gubertini G; Broggi M J Thromb Thrombolysis; 2020 Nov; 50(4):822-824. PubMed ID: 32757154 [No Abstract] [Full Text] [Related]
19. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection. Di Perri G Infez Med; 2020 Jun; 28(suppl 1):52-56. PubMed ID: 32532939 [TBL] [Abstract][Full Text] [Related]
20. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019. Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]